Blueshift Asset Management, LLC Heron Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $36,833 - $74,358	13,847 New	13,847 $58,000
Q1 2022 May 12, 2022	SELL	$4.63 - $9.94 $127,292 - $273,280	-27,493 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.35 - $12.6 $229,566 - $346,411	27,493 New	27,493 $251,000
Q2 2021 Aug 13, 2021	SELL	$13.27 - $18.48 $374,492 - $521,524	-28,221 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$14.49 - $20.72 $408,922 - $584,739	28,221 New	28,221 $457,000
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $149,847 - $232,073	-8,851 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$23.15 - $28.34 $204,900 - $250,837	8,851 New	8,851 $216,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.